Linda M Rubinstein insider trades

Open-market stock purchases and sales by Linda M Rubinstein, CHIEF FINANCIAL OFFICER at Adverum Biotechnologies, Inc, from SEC Form 4 filings since Jul 16, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +200%.

Recent trades

DateStockTradeValue
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$355K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$862K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)$444K
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncBought (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncSold (not open market)—
Dec 9, 2025ADVM Adverum Biotechnologies, IncBought (not open market)$205K

Companies traded

  • ADVM Adverum Biotechnologies, Inc: 1 buy, last Dec 9, 2025
  • BIOC Biocept Inc: other filings, last Jul 8, 2022

Get free alerts when Linda M Rubinstein files a new trade →